Health Press Release – Monthly Newsletter December 2010

General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience

CARLSBAD, California, November 1, 2010 – General Manifolds LLC, a technology company focused on fundamental
cognitive algorithms, announced today that the United States Patent and
Trademark Office has issued US Patent 7,805,386 covering a computational
system and method for simulating functions within the cerebral cortex of the
human brain. This ground-breaking technology is relevant to a broad range … Read : General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience.

Helsinn Announces License Agreement With Specialised Therapeutics for Palonosetron in Australia

Leading Anti-Nausea Drug Available to Australian and New Zealand Cancer Patients

LUGANO, Switzerland and MELBOURNE, Australia, November 1, 2010 – Australians can now access a new drug to prevent acute (and delayed
phase) nausea and vomiting which may occur in cancer patients undergoing
chemotherapy(1). This follows an agreement between the Swiss pharmaceutical
group Helsinn and Specialised Therapeutics Australia … Read this article on Gaea Times at : Helsinn Announces License Agreement With Specialised Therapeutics for Palonosetron in Australia.

Anemia – Pipeline Assessment and Market Forecasts to 2017 Now Available Sandler Research

DALLAS, November 1, 2010 – Sandler Research announces it will carry Anemia – Pipeline Assessment and
Market Forecasts to 2017 Research Report in its store.

Browse the complete Report on:
www.sandlerresearch.org/reports/37162-anemia-pipeline-assessment-and-m
arket-forecasts-to-2017.html
Browse All Food and Beverages Reports:
www.sandlerresearch.org/market-research/pharmaceuticals/
Search More Then 20000 Market Research Reports at
www.sandlerresearch.org/
…. Source  : Anemia – Pipeline Assessment and Market Forecasts to 2017 Now Available Sandler Research.

Peripheral Arterial Disease (PAD) – Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports

DALLAS, November 1, 2010 – ReportsandReports announces it will carry Peripheral Arterial Disease
(PAD) – Pipeline Assessment and Market Forecasts to 2017 Research Report in
its store.

Browse the complete Report on:
www.reportsnreports.com/Reports/37204-peripheral-arterial-disease-pad-
pipeline-assessment-and-marke.html
Browse All Manufacturing & Construction Reports:
www.reportsnreports.com/market-research/pharmaceuticals/
Browse All GlobalData Research Reports at
www.reportsnreports.com/publishers/globaldata/
… Read this article on Gaea Times at : Peripheral Arterial Disease (PAD) – Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports.

Installation of a Second CyberKnife(R) Robotic Radiosurgery System in Vicenza Hospital

Vicenza, the First Facility to Have Offered CyberKnife Radiosurgery in Europe, Increases its Capacity to Treat More Cancer Patients with the Installation of a Second System

SUNNYVALE, California, November 1, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, announced today that Vicenza Hospital, Ospedale Civile San
Bortolo in Italy, has become [..] Read the original article: here.

Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation

BOZEN, Sud-Tirol, Italy, November 1, 2010 – Health Robotics today announced that it recently signed an exclusive
distribution agreement in Norway for its CytoCare, i.v.STATION, and i.v.SOFT
world-leading technologies with local Pharmacy Technology leader Beckman
Automation AS. This partnership represents Health Robotics' market entry into
its 12th new country in 2010, persisting on its worldwide quest to
pervasively provide … Read more »»».

Delivering on Jobs, Prosperity, Schools and Hospitals but “More to do” Says RB

LUSAKA, Zambia, November 1, 2010 – Tomorrow, 2 November 2010, marks two years since His Excellency Mr Rupiah
Banda became President of Zambia.

President Banda succeeded the late President Levy Mwanawasa in November
2008, promising to build on his predecessor's achievements by campaigning on
the themes of 'Continuity, Good Governance and Prosperity for All.'
…. Original article on Gaea Times at  : Delivering on Jobs, Prosperity, Schools and Hospitals but "More to do" Says RB.

Genesis, The Biomimetic Implant System(TM), Receives Regulatory Clearance

A Major Advance in Aesthetic Implant Dentistry Launches in the U.S.
BURLINGTON, Massachusetts, November 1, 2010 – Keystone Dental, Inc. today announced U.S. regulatory clearance of
Genesis, The Biomimetic Implant System. The Genesis System represents a major
advance in implant dentistry through its biomimetic design – a design
inspired by nature. The unique benefits of the Genesis System … Read this article on Gaea Times at : Genesis, The Biomimetic Implant System(TM), Receives Regulatory Clearance.

European Food Makers in Race to Softer Health Claims

Innova Market Insights (HiE, Madrid, Stand: R84)
DUIVEN, The Netherlands, November 2, 2010 – New product development in the European supplements sector is slowing
down and food product manufacturers are switching to more general claims in
the healthy foods space, as uncertainty around EFSA health claims
(www.innovadatabase.com/home/index.rails) continues.

Innova Market Insights tracked 384 new supplement … Original article on : European Food Makers in Race to Softer Health Claims.

Ingenuity Systems and Geospiza Collaborate to Create Seamless Next-Generation Sequencing Workflow

REDWOOD CITY, California, November 3, 2010 – Ingenuity(R) Systems, a leading provider of information solutions for
life science researchers, and Geospiza, Inc., the market leading developer of
laboratory management and genetic analysis software, today announced a
collaboration to enable a seamless next-generation sequencing analysis
workflow. The companies will integrate their software products, GeneSifter(R)
and IPA(R), to enable researchers to … Read : Ingenuity Systems and Geospiza Collaborate to Create Seamless Next-Generation Sequencing Workflow.

Cellonis’ Cell Treatment for Glioma May Prevent Tumor Recurrence and Improve Quality of Life Significantly

BEIJING, November 3, 2010 – "For brain cancer patients after surgery, the combined DC-CIK and stem
cell therapy from Cellonis Biotechnologies can be a very effective method in
preventing cancer recurrence," says renowned cancer doctor Dr. Dinggang Li.
"This is a new hope for cancer patients."

The unique therapy combines the latest stem cell …. Source article on Gaea Times at  : Cellonis' Cell Treatment for Glioma May Prevent Tumor Recurrence and Improve Quality of Life Significantly.

New Report Pet Insurance in North America, 4th Edition Now Available at Sandler Research

DALLAS, November 3, 2010 – Sandler Research announces it will carry Pet Insurance in North
America, 4th Edition Research Report in its store.

Browse the complete Report on:
www.sandlerresearch.org/reports/38160-pet-insurance-in-north-america-
4th-edition.html
Browse All Food and Beverages Reports:
www.sandlerresearch.org/market-research/banking-services/
Search More Than 20000 Market Research Reports at
www.sandlerresearch.org/
Browse …. Read the original article  : here.

MarketsandMarkets: Global Thin Film Photovoltaics (PV) Market Worth $19,422 Million in 2015

DALLAS, November 3, 2010 – Low cost and optimum efficiency of thin film PV cells is driving the
growth of the thin film PV in overall photovoltaic market. The global thin
film photovoltaic market (
www.marketsandmarkets.com/Market-Reports/thin-film-pv-31.html) is
expected to grow from $3,406 million in 2009 to $19,422 million in 2015, at
an estimated CAGR of 32.2% from 2010 to …. Source article  : MarketsandMarkets: Global Thin Film Photovoltaics (PV) Market Worth $19,422 Million in 2015.

D-Pharm Ltd Appoints CRO for Clinical Development of DP-b99 in China

REHOVOT, Israel, November 3, 2010 – D-Pharm (TASE: DPRM) announced today the appointment of Hangzhou
Tigermed Consulting Co., Ltd as the contract research organization to manage
the regulatory filings and conduct the clinical trials of DP-b99, in China.
The agreement was signed together with Wanbang Biopharmaceuticals, as part of
the D-Pharm – Wanbang co-development program for DP-b99 in …. Source article  : D-Pharm Ltd Appoints CRO for Clinical Development of DP-b99 in China.

New Report European Vaccine Markets Now Available at ReportsnReports

DALLAS, November 3, 2010 – ReportsandReports announces it will carry European Vaccine Markets
Research Report in its store.

Browse the complete Report on:
www.reportsnreports.com/Reports/38156-european-vaccine-markets.html
Browse All Manufacturing & Construction Reports:
www.reportsnreports.com/market-research/medical-devices/
Browse All Kalorama Research Reports at
www.reportsnreports.com/publishers/kalorama-information/
The European vaccines market has demonstrated growth even …. Read the original article  : here.

IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITAS(TM)

New SUPERA(R) Delivery System Improves Procedure Predictability and Stent Performance

WEBSTER, Texas, November 3, 2010 – IDEV Technologies, Incorporated (IDEV), an innovative leader in the
development and commercialization of minimally invasive medical technologies,
today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to
market the SUPERA VERITAS Transhepatic Biliary System.
SUPERA VERITAS is the …. Source article on Gaea Times at  : IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITAS(TM).

Thrifty White Drug Stores Chooses Gold Standard/Elsevier to Improve its Drug Dispensing System

Pharmacists and Patients at Employee-Owned Retailer Will Use Alchemy for Accurate, Timely Medication Knowledge

TAMPA, Florida, November 3, 2010 – Gold Standard/Elsevier, developer of drug information and medication
management solutions, announced today that Thrifty White Drug Stores, an
employee-owned pharmacy with 88 stores in six states, has licensed Alchemy
(www.goldstandard.com/pages/alchemy.html?epm=1_1) as the new drug
database and decision support solution …. Source article on Gaea Times at  : Thrifty White Drug Stores Chooses Gold Standard/Elsevier to Improve its Drug Dispensing System.

Greener Pastures for Trimega in Manchester

LONDON, November 3, 2010 – Trimega Laboratories is looking to rapidly expand its Local Government
business, having achieved ISO 14001 certification for its Manchester-based
substance abuse testing facilities.

The ISO 14001 standard, which is used by organisations to design and
implement an effective environmental management system, is now often a
pre-requisite for Local Authorities in … Original source on Gaea Times at : Greener Pastures for Trimega in Manchester.

The “Piece of the Mind” Responsible for Peace of Mind

Ground-breaking research could lead to new treatments for anxiety disorders and depression

LONDON, November 3, 2010 – Researchers from King's College London, in partnership with AXA, have
initially identified the neural pathways that control peace of mind in the
human brain. The research project could lead to the development of new
therapies in the treatment of anxiety disorders … Read the original article on Gaea Times at : The "Piece of the Mind" Responsible for Peace of Mind.

Bluestar Silicones Introduces its New Silbione(R) Products for Healthcare at MEDICA 2010 in Dusseldorf

LYON, France, November 4, 2010 – Bluestar Silicones introduces its new Silbione(R) products at MEDICA 2010
in Dusseldorf for Healthcare (17. – 19. November 2010) to showcase its
innovative skin-friendly Silbione(R) range of silicones products

Designed specifically for the global healthcare market, the Silbione(R)
brand of specialty silicones offers high quality and innovative material
solutions … Read the original article on Gaea Times at : Bluestar Silicones Introduces its New Silbione(R) Products for Healthcare at MEDICA 2010 in Dusseldorf.

Interventional Spine(R), Inc. Announces Issuance of Key Patents for the PERPOS(R) PLS System

IRVINE, California, November 4, 2010 – Interventional Spine(R), Inc. today announced that the United States
Patent Office has issued U.S. Patent No. 7,824,429, entitled Method and
Apparatus for Spinal Fixation. This patent includes 43 claims that provide
key patent protection for the Company's percutaneous transfacet-pedicular
compression system for posterior spine fixation sold under the PERPOS(R) PLS
System name and … Original article on : Interventional Spine(R), Inc. Announces Issuance of Key Patents for the PERPOS(R) PLS System.

Able Home Life Announce Unique 12 Month Guarantee

BISHOP'S STORTFORD, England, November 4, 2010 – Able Home Life, the recently launched mobility website, is putting
customer satisfaction above short-term business gain by offering a Total
Satisfaction Guarantee across all 3,500 of its healthcare and lifestyle
products. The 12 month satisfaction guarantee is designed to encourage
customer buying confidence; something that is still under strain due to …. Original article  : Able Home Life Announce Unique 12 Month Guarantee.

Cheetah Medical’s NICOM(R) System for Noninvasive Hemodynamic Monitoring Found to be an Effective Tool for Identification of Acute Heart Failure in the Emergency Department

Cleveland Clinic Researchers Find That NICOM(R) Technology Provides a Quick Noninvasive Tool to Help Diagnose Acute Heart Failure in Patients Presenting to the Emergency Department With Shortness of Breath

TEL AVIV, Israel, November 4, 2010 – A study performed by investigators from the Emergency
Department of the Cleveland Clinic Foundation finds that Cheetah Medical's
NICOM system is … Read more »»».

MedImmune Announces Winners of European Cancer Research Abstract Competition

CAMBRIDGE, England, November 4, 2010 – Today MedImmune announced the winners of its second annual European
research abstract competition which highlights the research of the next
generation of scientific leaders in cancer research. Students and
postdoctoral fellows from across Europe were invited to submit abstracts
describing their research in the field of tumour microenvironments as part of
the competition … Read more : MedImmune Announces Winners of European Cancer Research Abstract Competition.

bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics

MARCY L'ETOILE, France and LAUSANNE, Switzerland, November 4, 2010 -

– Co-development of Assays and Co-distribution of a Fully Integrated
Molecular Platform due for Launch in 2012

– bioMerieux Gains Exclusive Rights in Microbiology

– bioMerieux Takes Equity Stake in … Read the original article on Gaea Times at : bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics.

Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries

ABBOTT PARK, Illinois, November 5, 2010 – Scrip, a leading global pharmaceutical and biotech news organization,
honored Abbott (NYSE: ABT) with two 2010 Scrip Awards for its business
excellence and strong management.

"We are honored to receive these two prestigious awards on behalf of our
90,000 employees worldwide," said Miles D. White, chairman and …. Source  : Gaea News Network.

Serono Symposia International Foundation (SSIF) “The Biological Basis of Progressive MS”

Towards Improvement of Future Management of Progressive Forms of MS
ROME, November 5, 2010 – Some of the most experienced clinicians and scientists working
in the field of multiple sclerosis will gather in Montreal on November the
6th during the Symposium- "The biological basis of progressive MS held by
Serono Symposia International Foundation," in order to discuss the … Read more >>>.

Hoya Announces Second Quarter Financial Results

TOKYO, November 5, 2010 – HOYA Corporation today announced financial results for the second quarter
ended September 30, 2010. Net sales were up 0.2% to 107,075 million yen
year-on-year, and operating income rose 0.3% to 18,768 million yen. Net
income was up 24.5% to 12,891 million yen, and earnings per share were 29.88
yen compared with 23.91 yen [..] Read the original article: here.

Gen-Probe Launches the ELUCIGENE(TM) KRAS.BRAF Kit to Detect Genetic Mutations That Help Determine Colorectal Cancer Treatment

First Single-Tube Assay to Simultaneously Detect Seven KRAS and One BRAF Mutations

MANCHESTER, England, November 8, 2010 – Gen-Probe Incorporated (Nasdaq: GPRO) has launched in Europe the
ELUCIGENE(TM) KRAS.BRAF kit, a highly sensitive, single-tube assay designed
for the simultaneous quantitative detection of seven common KRAS mutations
and the V600E BRAF mutation. The CE-marked assay provides valuable
information regarding mutation …. Read the original article  : here.

Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca(R) and Stretta(R) Systems

GREENWICH, Connecticut, November 8, 2010 – Mederi Therapeutics Inc announced today that it has received a CE Mark
authorizing the European distribution and use of Mederi's second generation
of the Stretta and Secca Systems. The Stretta System is for treatment of
gastric reflux disease, commonly known as GERD, and the Secca System is for
treatment of bowel control … Read : Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca(R) and Stretta(R) Systems.

Elsevier’s Scival(R) Spotlight(TM) Country Maps Provide a National Perspective of Interdisciplinary Research

AMSTERDAM, November 8, 2010 – Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, today announced the availability
of SciVal Spotlight country maps (www.info.scival.com). The country
maps are a new option for academic and governmental decision makers seeking
to understand national research strengths against the increasingly
interdisciplinary backdrop of global research. They are an extension …. Original source  : Elsevier's Scival(R) Spotlight(TM) Country Maps Provide a National Perspective of Interdisciplinary Research.

Scottish Medicines Consortium Approves Zebinix – Once Daily Anti-Epileptic Treatment

LONDON, November 8, 2010 – Zebinix(R) (eslicarbazepine acetate), a treatment for epilepsy, has been
accepted for restricted use in Scotland after a decision by The Scottish
Medicines Consortium (SMC).[1] Following the new clinical and cost
effectiveness decision, Zebinix can now be used as an add-on (adjunctive)
therapy in adults with partial-onset seizures, with or without secondary
generalisation (where the …. Source  : Gaea News Network.

Abbott Presents Data Exploring Relationship of Physical Function to Inflammation and Structural Damage in RA

ABBOTT PARK, Illinois, November 8, 2010 – Today, Abbott (NYSE: ABT) presents results from a pooled analysis of two
pivotal HUMIRA(R) (adalimumab) studies, which look at patients with early and
long-standing moderate to severe rheumatoid arthritis (RA), at the American
College of Rheumatology meeting in Atlanta.

The study looked at inflammation and structural damage … Read this article on Gaea Times at : Abbott Presents Data Exploring Relationship of Physical Function to Inflammation and Structural Damage in RA.

Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa

ABBOTT PARK, Illinois, November 8, 2010 – Abbott (NYSE: ABT) and the Clinton Health Access Initiative (CHAI) have
joined forces to provide HIV testing to infants in all countries working in
partnership with the CHAI. A key focus of this cooperation will be
sub-Saharan Africa, which the World Health Organization estimates to account
for 90 percent of global …. Source article on Gaea Times at  : Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa.

Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions

PARIS, November 8, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has
sent a letter to Genzyme Corporation (Nasdaq: GENZ) requesting that Genzyme
clarify its position on a number of potential Board actions raised in
Genzyme's Schedule 14D-9.

Sanofi-aventis' letter also notes that it is encouraged by Genzyme's
decision to "probe … Read the original article on Gaea Times at : Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions.

Gerresheimer Opens a Representative Office in India

Gerresheimer Steps Up Business Operations in Emerging Markets
DUSSELDORF, Germany, November 9, 2010 – Gerresheimer AG, one of the world's leading suppliers to the
pharma and healthcare industry, is still expanding its global operations. The
establishment of a representative office in Mumbai/India reflects the
company's commitment to the strategy of profiting from the consistent growth
in emerging markets.

… Read : Gerresheimer Opens a Representative Office in India.

Ziehm Imaging and Medtronic Present Interface for Image-Guided 3D Navigation

Raising Reliability Standards in the OR With Distortion-Free Intraoperative 3D Imaging

NUREMBERG, Germany, November 9, 2010 – Medical technology players Ziehm Imaging and Medtronic teamed up to
improve the use of 3D imaging together with intraoperative navigation. The
Ziehm Vision FD Vario 3D C-arm now connects to Medtronic's StealthStation(R)
navigation system over the Ziehm NaviPort interface to deliver
distortion-free …. Original article  : Ziehm Imaging and Medtronic Present Interface for Image-Guided 3D Navigation.

Shire Finalises its Acquisition of Movetis NV Following Completion of the Squeeze-Out Process

DUBLIN, November 9, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its wholly owned subsidiary Shire
Holdings Luxembourg S.??.r.l. has now acquired all of the issued shares and
warrants of Movetis NV.

Shares in Movetis NV have now been delisted from Euronext Brussels. The
last trading day was … Original article on : Shire Finalises its Acquisition of Movetis NV Following Completion of the Squeeze-Out Process.

New Assay-Ready Chemical Supply Service Launched by Peakdale and Molplex

NEWCASTLE-UPON-TYNE and CHAPEL-EN-LE-FRITH, England, November 9, 2010 – A pioneering new assay-ready, on-demand chemical supply
service has been announced today as the result of a partnership between
Molplex and Peakdale Molecular.

The new service will radically cut the cost of accessing
chemical libraries for drug discovery by providing sophisticated chemical
selection systems, allowing customers to … Read more : New Assay-Ready Chemical Supply Service Launched by Peakdale and Molplex.

International Medical News Group Launches Cardiology Product Zone in Partnership With Pure Incubation

MORRISTOWN, New Jersey, November 9, 2010 – International Medical News Group, LLC, an Elsevier company
that provides medical news and information to physicians, announced today the
launch of Cardiology Product Zone. This new product resource guide is
launched in partnership with Pure Incubation, a company that specializes in
developing data driven web properties and performance media programs that … Read the original article on Gaea Times at : International Medical News Group Launches Cardiology Product Zone in Partnership With Pure Incubation.

Elsevier Announces New Brain Research Editor-In-Chief

New Appointment Aimed at Maintaining the Ethos, Heritage and Uniqueness of This Pioneering Journal in the Field of Neuroscience

OXFORD, England, November 9, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and solutions, is pleased to announce that Dr. Irwin
B.Levitan has accepted the position of Editor-in-Chief of the journal Brain
Research. He …. Original source  : Elsevier Announces New Brain Research Editor-In-Chief.

Elsevier Supports Doctors Without Borders for Second Year Through ‘The Great Giveback’ Campaign

Percentage of Revenues From MD Consult Subscriptions Sold in Nov.-Dec. to go to Medical Relief Organization Which won the Nobel Peace Prize in 1999

PHILADELPHIA, November 9, 2010 – Elsevier, (www.elsevier.com/wps/find/homepage.cws_home)
the world-leading publisher of scientific, technical and medical information
products and services, announced today that it will contribute to Doctors
Without Borders/Medecins Sans Frontieres (MSF) (
www.doctorswithoutborders.org/) through … Original article on : Elsevier Supports Doctors Without Borders for Second Year Through 'The Great Giveback' Campaign.

Paris Pharma Events Smash All Attendance Records

Attendees up by 14%,* Exhibitor Numbers Increase to 1934.
AMSTERDAM, November 9, 2010 – Leading events organiser, UBM Live, today announced record numbers of
attendees at its flagship Pharma event, CPhI Worldwide 2010 in Paris, France.
Along with co-located events, P-MEC Europe for equipment, machinery and
technology; ICSE for contract services, clinical trials and packaging; and
BioPh for the …. Source article  : Paris Pharma Events Smash All Attendance Records.

Biggest Ever ICSE Attracts Record Attendance

AMSTERDAM, November 9, 2010 – Leading event organiser, UBM Live
(www.cmpi.biz/ubminternationalmedia), today announced that its annual
flagship pharmaceutical contract services event , ICSE Europe
(www.icsexpo.com), (Villepinte, Paris Nord 5-7 October), along with
co-located events CPhI Worldwide for pharmaceutical ingredients; P-MEC Europe
for equipment, machinery and technology and BioPh Europe for biopharma, had
attracted an increase in visitors of over 14%* …. Source article on Gaea Times at  : Biggest Ever ICSE Attracts Record Attendance.

New Drugs & Alcohol Advisory Board Established

LONDON, November 9, 2010 – A new Hair Strand Scientific Advisory Board has been
established by UK-based Trimega Laboratories. Its purpose is to analyse the
fast growing database of information created from the 10,000 hair alcohol
tests and 7,000 hair drug tests carried out in the UK each year, of which
Trimega Laboratories is responsible for around 40%.

…. Source article  : New Drugs & Alcohol Advisory Board Established.

Five-Year Market Exclusivity for VYVANSE(R) Upheld

United States Court of Appeals for the District of Columbia Circuit Reaffirms NCE Exclusivity

PHILADELPHIA, November 10, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that the U.S. Court of Appeals for the
District of Columbia Circuit has affirmed the ruling of the U.S. District
Court for the District of Columbia and … Read the original article on Gaea Times at : Five-Year Market Exclusivity for VYVANSE(R) Upheld.

Elsevier to Publish Psychosomatics: Official Journal of the Academy of Psychosomatic Medicine

Publishing Partnership to Help Advance Excellence in Consultation-Liaison Psychiatry

NEW YORK, November 10, 2010 – Elsevier, the world's leading publisher of scientific, technical and
medical information, announced today that it is partnering with the Academy
of Psychosomatic Medicine (APM) to publish Psychosomatics, the official
journal of the Academy of Psychosomatic Medicine. The announcement, made at
the annual APM meeting …. Source  : Gaea News Network.

MarketsandMarkets: Worldwide Electronic Medical Records (EMR) Market to be US$ $9,957 Million By 2015

DALLAS, November 10, 2010 – The 'Worldwide Electronic Medical Records (EMR) Market, 2010-2015
(www.marketsandmarkets.com/Market-Reports/EMR-market-253.html )
(market share, winning strategies and adoption trends)' analyzes the EMR
market by end users, components and applications and studies the major market
drivers, restraints, and opportunities for the Electronic Medical Records
market in North America, Europe, Asia and ROW.

Browse market [..] Read the original article: here.

AB Therapeutics New Anticancer Compounds Reduce by 70% Lung Tumors Growth

The Barcelona Based Biotech Company is in a Series-A Fundraising Round to Conduct Preclinical Development and to File an IND in Late 2011

BARCELONA, November 10, 2010 – The Barcelona-based biotech company AB Therapeutics has obtained high
efficacy results with its 2 new anticancer compounds in animal models of lung
cancer (NSCLC) using Membrane Lipid Therapy (MLT), … Original article on : AB Therapeutics New Anticancer Compounds Reduce by 70% Lung Tumors Growth.

UNICEF Partners With frog design for Major mHealth Initiative

frog launches 'Mobile Mandate,' a new collaboration model to drive social innovation through mobile technology

SAN FRANCISCO, November 10, 2010 – frog design today announced a collaboration with UNICEF as the
organization's lead design and innovation partner on Project Mwana, a major
mHealth initiative to improve maternal and infant health and welfare in
peri-urban Malawi and rural Zambia. … Read : UNICEF Partners With frog design for Major mHealth Initiative.

Growth in Indian Pharma Market Reflected in Expected Record Numbers for CPhI, P-MEC, ICSE and BioPh India 2010 Events

Mumbai All Set for Biggest Ever Indian Pharma Event
AMSTERDAM, November 10, 2010 – Reflecting the rapid growth in the Indian Pharma market, leading events
organiser UBM Live today announced that it expects to see a record number of
attendees at its upcoming trade events, CPhI India for pharmaceutical
ingredients and intermediates, and co-located events, P-MEC for equipment … Read this article on Gaea Times at : Growth in Indian Pharma Market Reflected in Expected Record Numbers for CPhI, P-MEC, ICSE and BioPh India 2010 Events.

IIP Recognition for Trimega Laboratories

LONDON, November 10, 2010 – UK based Trimega Laboratories is pleased to announce that it has been
recognised as having met the standards set by the prestigious Investors in
People (IIP) Standard.

Its accreditation follows an examination by the Employer Representative
Quality Board of IIP and reflects the commitment and hard work undertaken by
Trimega … Read the original article on Gaea Times at : IIP Recognition for Trimega Laboratories.

Almac’s Clinical Technologies Business Unit Again Receives ‘Best Places to Work in PA 2010′ Award

SOUDERTON, Pennsylvania, November 10, 2010 – Almac's Clinical Technologies business unit, a part of the Almac Group,
has been named one of the Best Places to Work in PA for 2010. The awards
program, created in 2000, is one of the first statewide programs of its kind
in the country. The program is a public/private partnership between … Read : Almac's Clinical Technologies Business Unit Again Receives 'Best Places to Work in PA 2010' Award.

Waters Corporation Welcomes King’s College London into Waters Centers of Innovation Program

Aim is to Support the Drug Control Centre's Efforts to Develop Novel Analytical Methods for Sports Drug Testing and Toxicological Studies

MILFORD, Massachusetts, November 10, 2010 – Waters Corporation (NYSE: WAT) today welcomed into its Centers of
Innovation Program the Drug Control Centre within the Department of Forensic
Science and Drug Monitoring at King's College London.
…. Original article on Gaea Times at  : Waters Corporation Welcomes King's College London into Waters Centers of Innovation Program.

Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair

RICHMOND, Virginia, November 10, 2010 – Filtrona Porous Technologies, a custom developer and manufacturer of
medical grade foam and fiber components designed to absorb, retain, transfer,
filter or release fluids or vapors, will display an expanded range of
polyurethane foams and bonded fibers at the MEDICA / COMPAMED trade fair in
Dusseldorf, Germany from 17 to 19 November … Original source on Gaea Times at : Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair.

Inaccurate Reporting on Recent Omega-3 DHA Alzheimer’s Study Reveals Misrepresentation by Media

DARTMOUTH, Nova Scotia, November 10, 2010 – Several media outlets published articles last week suggesting that
Omega-3 fish oil supplements fail to show positive results for Alzheimer's
patients. This reporting by media outlets came after the Journal of the
American Medical Association (JAMA) published the study "Docosahexaenoic Acid
Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized
Trial", where …. Source article on Gaea Times at  : Inaccurate Reporting on Recent Omega-3 DHA Alzheimer's Study Reveals Misrepresentation by Media.

Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder

ANTONY, France, November 10, 2010 – Following the announcement that Wendel had entered exclusive
negotiations with Ares Life Sciences on October 28, 2010, with a view to
selling its entire stake (around 46%) in Stallergenes, the company's Works
Council met on November 10, 2010.

Stallergenes' Works Council having returned a positive
consultative opinion at this … Original article on : Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder.

FDA Approves EGRIFTATM (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients With Lipodystrophy

Clinical Trials Demonstrate Reduction in Visceral Adipose Tissue and Waist Circumference

GENEVA, November 11, 2010 – Merck Serono, the pharmaceutical division of Merck KGaA,
Darmstadt, Germany, today announced that the U.S. Food and Drug
Administration (FDA) has approved EGRIFTA(TM) (tesamorelin for injection) as
the first and only treatment indicated to reduce excess abdominal fat in
HIV-infected patients with lipodystrophy … Read more »».

Saunders Solutions for Vets Professional Skills Online-course Suite Wins a Prestigious 2010 Brandon Hall Excellence in Learning Award

LONDON, November 11, 2010 – Elsevier's Vet CPD Professional Skills online courses have won a
coveted Brandon Hall award for excellence as 'Best Custom Content'. The suite
of five 'How To…' case-study courses build on the innovative e-learning
approach established by the trailblazing 'How to Achieve Effective
Compliance' course, created by Elsevier and its developers in conjunction
with veterinary … Read : Saunders Solutions for Vets Professional Skills Online-course Suite Wins a Prestigious 2010 Brandon Hall Excellence in Learning Award.

IndiaMART.com To Spur Indian Dental Business Through Famdent Show 2010

To Sponsor India's Leading Dental Event, Which Blends Knowledge-Sharing With Trade Exposition, for the Second Time

NEW DELHI, November 12, 2010 – Translating its objective of assisting Small and Medium
Enterprises (SMEs) in discovering new avenues and connecting with
establishments from across the globe, IndiaMART.com, India's largest online
B2B marketplace, has decided to associate with Famdent, a leading … Read the original article on Gaea Times at : IndiaMART.com To Spur Indian Dental Business Through Famdent Show 2010.

MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015

DALLAS, November 12, 2010 – The 'Top 10 drug discovery technologies
(www.marketsandmarkets.com/Market-Reports/drug-discovery-41.html) -
strategic analysis and global forecasts (2010 to 2015)' analyzes the top 10
drug discovery technologies with respect to market drivers, opportunities and
trends in the diverse geographical regions including North America, Europe,
Asia and rest of the world.

Browse market data tables and … Original source on Gaea Times at : MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015.

Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema

RESEARCH TRIANGLE PARK, North Carolina, November 15, 2010 – Talecris Biotherapeutics announced today the publication of combined data
from two studies demonstrating that augmentation therapy with Alpha(1)
-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss
in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
Results of the studies, published as an integrated analysis of the raw data
from …. Source  : Gaea News Network.

BioWa Announces License of POTELLIGENT(R) Technology to Agensys

PRINCETON, New Jersey, November 15, 2010 – BioWa, Inc. announced today that it has entered into a license agreement
with Agensys, Inc., an affiliate of Tokyo based Astellas Pharma Inc.,
providing Agensys with access to BioWa's POTELLIGENT(R) Technology platform
for the purpose of identifying antibodies with enhanced antibody-dependent
cellular cytotoxicity (ADCC).

"We are extremely pleased …. Source article on Gaea Times at  : BioWa Announces License of POTELLIGENT(R) Technology to Agensys.

Menicon Expands Partnership with Optimed in North America

Menicon exclusively distributes Optimed's innovative patient education software in North America-

NAGOYA, Japan, November 15, 2010 – Menicon Co., Ltd. has announced its agreement with Optimed Ltd. to become
the exclusive distributor for Optimed's CAPTIV8 communication services and
i-Vue content-driven digital signage software for North America. Earlier this
year, Menicon obtained exclusive distribution rights for Optimed's products
in Japan …. Source article  : Menicon Expands Partnership with Optimed in North America.

Teva UK Limited Enters Wounds Sector With PolyHeal(TM) Launch

CASTLEFORD, England, November 15, 2010 – Teva UK Limited, a leading supplier of medicines to the NHS, has today
entered the Wound Care sector with the launch of PolyHeal (TM) at the Wounds
UK conference. PolyHeal is a product for hard-to-heal wounds and has been
clinically shown to result in a significant reduction in wound size after
just …. Original article  : Teva UK Limited Enters Wounds Sector With PolyHeal(TM) Launch.

APPG Hosts UK Event for World Pneumonia Day 2010 to Fight the World’s Leading Killer of Children Under Five

LONDON, November 15, 2010 – In support of World Pneumonia Day 2010, leaders in the fight
against pneumonia will gather in London on Tuesday 16 November for a
roundtable briefing from the All Party Parliamentary Group (APPG) for Global
Action Against Childhood Pneumonia. The meeting will highlight the progress
made since the inaugural World Pneumonia Day in 2009; …. Original source  : APPG Hosts UK Event for World Pneumonia Day 2010 to Fight the World's Leading Killer of Children Under Five.

Crystal Clear Health Literacy Awards 2011- Helping Your Patients Understand

DUBLIN, November 15, 2010 – The MSD/NALA Health Literacy Initiative is delighted to announce the
launch of the fourth Crystal Clear MSD Health Literacy Awards. Continuing to
gain momentum since their inaugural launch in 2007 the awards are designed to
recognise and reward excellence in health literacy in the healthcare sector.
Health Literacy is increasingly being recognised as …. Original article on Gaea Times at  : Crystal Clear Health Literacy Awards 2011- Helping Your Patients Understand.

Burcon and ADM Enter Into CLARISOY(R) Letter of Intent

VANCOUVER, November 15, 2010 – Burcon NutraScience Corporation (TSX – BU) ("Burcon") announced today
that it has signed a non-binding letter of intent (the "Letter of Intent")
with Archer Daniels Midland Company ("ADM") which details the intention of
the two parties to enter into a license agreement pursuant to which Burcon
will license (the "License") its CLARISOY(R) technology …. Original article  : Burcon and ADM Enter Into CLARISOY(R) Letter of Intent.

Chiltern Launches ‘Chiltern SAFE,’ a Comprehensive Global Trial Master File Management Solution

LONDON, November 15, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO), announced the launch of Chiltern SAFE.

"Chiltern SAFE is revolutionizing records management for clinical trials,
stated Sarah Hitching, Chiltern Director, Records Management. "This complete
electronic Trial Master File (TMF) solution facilitates remote management of
documents, which saves administrative time and …. Read the original article  : Chiltern Launches 'Chiltern SAFE,' a Comprehensive Global Trial Master File Management Solution.

Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist

439 new Titles Span 24 Diverse Subject Areas Bringing SciVerse ScienceDirect Total to 12,500 eBooks

ST. LOUIS, November 15, 2010 – Elsevier, the leading publisher of scientific, technical and medical
information products and services, announced today its 2011 eBook collections
available for advance purchase and to be released on SciVerse ScienceDirect,
its online scientific knowledge platform. The 2011 [..] Read the original article: here.

iFuse Implant System(TM) Receives CE Mark

SI-BONE commences surgeon training at labs in Salzburg, Austria
SAN JOSE, California, November 15, 2010 – SI-BONE, Inc. (San Jose, California), a medical device company that is
pioneering the use of a minimally invasive surgical (MIS) device to treat the
sacroiliac (SI) joint announced today that it has received a CE mark for its
iFuse Implant System(TM). A …. Original article on Gaea Times at  : iFuse Implant System(TM) Receives CE Mark.

Ingenuity Systems and Sage Bionetworks Collaborate to Enable Predictive Disease Network Research

REDWOOD CITY, California, November 16, 2010 – Ingenuity(R) Systems, a leading provider of information solutions for
life science researchers, today announced a new collaboration with Sage
Bionetworks, a non-profit leader in predictive disease network research.
Under the collaboration, Sage will leverage IPA(R), Ingenuity's
industry-leading analysis software, and the Ingenuity(R) Knowledge Base of
structured biomedical Findings, to inform and enhance …. Original article  : Ingenuity Systems and Sage Bionetworks Collaborate to Enable Predictive Disease Network Research.

Edwards SAPIEN Transcatheter Heart Valve Demonstrates Substantial Improvement in Quality of Life in Inoperable Patients

IRVINE, California, November 16, 2010 – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, announced that in
addition to the improved survival seen in inoperable aortic stenosis patients
treated with the Edwards SAPIEN transcatheter heart valve in The PARTNER
Trial, a newly released analysis of the same patients shows [..] Read the original article: here.

Elsevier Launches SciVerse Applications Beta…Enabling the Research Community to Deliver a New Era in Scientific Search and Discovery

Release of Content APIs Empowers Developers to Create New Tools to Accelerate Science and Offers Platform for Sharing with the Global Scientific Community

AMSTERDAM, November 16, 2010 – Elsevier (www.elsevier.com) , a world-leading publisher of
scientific, technical and medical information products and services, today
announced the launch of SciVerse Applications beta, a new module within the
SciVerse platform … Read more >>.

IntraLinks Enhances Study Management Offering; Expands its Suite of SaaS-based Solutions for Clinical Operations

IntraLinks for Study Management Provides Unparalleled Automation and Insight Into Document-Centric Processes Throughout the Entire Clinical Trial Lifecycle

NEW YORK, November 16, 2010 – IntraLinks, a leading provider of critical information exchange
solutions, today announced IntraLinks for Study Management, a secure, online
platform for managing and monitoring all communication and activity with
investigative sites and other outside parties … Original article on : IntraLinks Enhances Study Management Offering; Expands its Suite of SaaS-based Solutions for Clinical Operations.

GRAVITAS Trial Shows That a Uniform Treatment Strategy of Doubling the Standard Dose of Plavix Does Not Improve Outcomes Post-PCI

Higher Cardiac Event Rates Seen in Patients with Higher Residual Platelet Reactivity, as Measured by the VerifyNow P2Y12 Test

SAN DIEGO, November 16, 2010 – Accumetrics, Inc., developer and marketer of the VerifyNow(R) System,
today announced that the GRAVITAS (Gauging Responsiveness With A VerifyNow
Assay-Impact On Thrombosis And Safety) Trial found that in patients with high
residual platelet … Read more : GRAVITAS Trial Shows That a Uniform Treatment Strategy of Doubling the Standard Dose of Plavix Does Not Improve Outcomes Post-PCI.

Isotechnika Reports Development, Distribution and Licencing Agreement and Private Placement Financing With ILJIN Life Science co., Ltd., Amendment of Arrangements With Paladin Labs Inc., and Related Matters

EDMONTON, Canada, November 16, 2010 – Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Corporation")
today announced that it has entered into a Development, Distribution and
License Agreement (the "DDL") with ILJIN Life Science Co., Ltd ("ILJIN") for
the further clinical and commercial development of voclosporin for use in
transplant indications applicable to voclosporin. Under the DDL in exchange
for … Read the original article on Gaea Times at : Isotechnika Reports Development, Distribution and Licencing Agreement and Private Placement Financing With ILJIN Life Science co., Ltd., Amendment of Arrangements With Paladin Labs Inc., and Related Matters.

Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device

First Ever CE Approved Combination Device is an Attractive Treatment for Coronary Artery Diseases

HELMOND, The Netherlands, November 16, 2010 – Blue Medical today announced that the company received CE Mark approval
for Blue Medical science based Drug Eluting Balloon (DEB) and simultaneously
for Blue Medical's coronary CoCr stent mounted on a Drug Eluting Balloon
(CoCr Stent on …. Source article  : Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device.

SuperSonic Imagine Announces That Gordon Waldron Has Been Named Executive Vice President and CFO

AIX-EN-PROVENCE, France, November 16, 2010 – SuperSonic Imagine, the innovative ultrasound medical imaging company, is
pleased to announce Gordon Waldron has been named as Executive Vice President
and CFO. As a member of the board of directors, he will be responsible for
driving all of SuperSonic Imagine's key strategic and commercial partnerships
as well as overseeing the company's …. Source article  : SuperSonic Imagine Announces That Gordon Waldron Has Been Named Executive Vice President and CFO.

Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients

MONT-SAINT-GUIBERT, Belgium, November 17, 2010 – The Belgian biotechnology company, Cardio3 BioSciences – a
leader in discovery and development of regenerative and protective therapies
for the treatment of cardiovascular diseases – today announces positive
six-month results, including significant functional and clinical benefit,
from the Phase II clinical trial of its development programme C-Cure(R),
designed as a novel stem cell … Read this article on Gaea Times at : Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients.

Mollie’s Fund Launches App for Skin Cancer Awareness

GARDEN CITY, New York, November 17, 2010 – The Mollie Biggane Melanoma Foundation, www.molliesfund.org has
announced the launch of a free application that will provide valuable
information for skin cancer and melanoma detection. This free application is
available on iPhone, iPod Touch and the iPad. It can also be downloaded
through iTunes.

Mollie's Fund, with …. Source article  : Mollie's Fund Launches App for Skin Cancer Awareness.

Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session

A Second AHA Presentation Includes Mouse Model Data Showing Plaque Reduction.

CHICAGO, November 17, 2010 – Resverlogix Corp. ("Resverlogix") (TSX:RVX) announces its top line
results of the ASSERT Phase 2 clinical trial which will be highlighted at the
prestigious American Heart Association Scientific Sessions 2010 Late Breaking
Clinical Trial session, by principal investigator Dr. Stephen Nicholls of the
Cleveland … Read this article on Gaea Times at : Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session.

Skin Rashes Caused by the use of Latex Gloves in Hospitals Soon to Become a Thing of the Past

DUSSELDORF, Germany, November 18, 2010 – A new technology is set to reduce the allergic potential of latex gloves
to virtually zero. Developed by the Dutch company Budev, the patented MPXXTM
technology is used to wash latex during manufacture. The new process and the
Cleantexx brand gloves made with it will be introduced at the MEDICA trade
fair … Read the original article on Gaea Times at : Skin Rashes Caused by the use of Latex Gloves in Hospitals Soon to Become a Thing of the Past.

UK Court of Appeal Publishes Decision in NPWT Case

Smith and Nephew Remains Committed to NPWT Market; will Continue to Serve Patients in United Kingdom

HULL, England, November 18, 2010 – The English Court of Appeal has published a decision in the long-running
dispute between KCI and Smith & Nephew relating to Negative Pressure Wound
Therapy (NPWT). The full implications of the decision will be finalized … Original source on Gaea Times at : UK Court of Appeal Publishes Decision in NPWT Case.

Elsevier Launches HESI QuizMe Nursing App Series

Customizable Quiz Apps for iPhone(R) and iPod touch(R) Help Students Build Nursing Knowledge

PHILADELPHIA, November 18, 2010 – Elsevier (www.elsevier.com/wps/find/homepage.cws_home), the
leading publisher of scientific, technical and medical information products
and services, today announced that the new HESI QuizMe app series for nursing
students is available from the Apple App Store. These apps familiarize
nursing students with clinically based … Read more »»».

Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering

ANDOVER, Massachusetts, November 18, 2010 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Atom Medical
Corporation, a major manufacturer of neonatal medical equipment, announced
today that they are expanding their relationship to serve customers with a
more complete portfolio of perinatal care solutions. This alliance now
includes neonatal patient monitoring, apnea home monitoring, neonatal
incubators and warmers, jaundice …. Original article  : Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering.

BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States

ccNexfin has an Unique Offering With Totally Noninvasive Beat-to-Beat Blood Pressure (BP), Cardiac Output (CO), and Masimo's Breakthrough Noninvasive Hemoglobin and Oxygen Saturation Measurements

AMSTERDAM, November 18, 2010 – BMEYE B.V., the innovators of combined totally noninvasive, beat-to-beat
blood pressure and cardiac output monitoring announces FDA clearance and the
United States launch of the BMEYE ccNexfin-the first …. Original article on Gaea Times at  : BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States.

DF Diary iPhone App Takes Diabetes Monitoring Mobile

MANCHESTER, England, November 18, 2010 – Diabetic Friend's DF Diary iPhone app is making monitoring food intake
much easier for those with diabetes. The application, designed by a Type 1
Diabetic, is powered by a comprehensive food database, incorporating dishes
from a growing number of restaurants. This enables users to quickly enter the
food they have eaten, thus …. Source  : Gaea News Network.

‘2010 China-Africa Brightness Action’ Launched in Beijing

Medical team heads for Africa via charter flight; about 1,000 cataract surgeries planned during one week

BEIJING, November 19, 2010 – The launching ceremony for the "2010 China-Africa Brightness
Action" was held at Deer Jet's fix base operation (FBO), Beijing Capital
International Airport on November 18. The charitable initiative, co-organized
by the China Association for Promoting Democracy (CAPD), …. Source  : Gaea News Network.

Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death

NATICK, Massachusetts, November 19, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced CE
Mark approval of its INCEPTA(TM), ENERGEN(TM) and PUNCTUA(TM) cardiac
resynchronization therapy defibrillators (CRT-Ds) and implantable
cardioverter defibrillators (ICDs). They are the Company's latest devices to
treat heart failure and sudden cardiac death.

These next-generation products are designed to advance patient
care with … Read the original article on Gaea Times at : Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death.

Patients With Common Heart Rhythm Disorder Demonstrated Improvements in Symptoms and Quality of Life With Catheter Ablation Compared to Treatment With Drug Therapy

WATERLOO, Belgium, November 22, 2010 – According to data published last week in Circulation
Cardiovascular Quality and Outcomes, patients with a common heart rhythm
disorder, called atrial fibrillation, who were treated with catheter ablation
using the NaviStar(R)ThermoCool(R) Catheter, reported markedly fewer symptoms
and substantially improved quality of life than patients treated with
antiarrhythmia drugs at one year.

… Read the original article on Gaea Times at : Patients With Common Heart Rhythm Disorder Demonstrated Improvements in Symptoms and Quality of Life With Catheter Ablation Compared to Treatment With Drug Therapy.

MEDICA and COMPAMED 2010: Strong Tailwind for Businesses – Closing Report

DUSSELDORF, Germany, November 22, 2010 – The manufacturers of medical technology and medical products have
weathered the phase of economic and financial crisis well, now noticing a
strong tailwind for their businesses and proving a driver for growth with
their innovations. This is the core message to be taken away from the four
days at the world's largest … Read more »»».

College of Direct Support Introduces New Learning Session Format, New Genre With ‘R&R Arcade’ for Reviewing, Refreshing Content

ATLANTA, November 22, 2010 – The College of Direct Support (CDS), an internet-based
curriculum for Direct Support Professionals (DSPs) and managed in partnership
by Elsevier/MC Strategies and the University of Minnesota's Research and
Training Center, has introduced its latest offering in the form of a new
genre of its online learning content. The new Learning Session is called …. Source  : College of Direct Support Introduces New Learning Session Format, New Genre With 'R&R Arcade' for Reviewing, Refreshing Content.

Grifols Announces US Launch of Flebogamma(R) 10% DIF IVIG

Building on the safety record of its 5% concentration, the new 10% liquid, room temperature IVIG preparation establishes Grifols as the only producer offering both 5% and 10% IVIG concentrations to healthcare providers and patients in the US

LOS ANGELES, November 22, 2010 – Grifols today announced availability of its recently approved
Flebogamma(R) 10% DIF intravenous …. Source  : Grifols Announces US Launch of Flebogamma(R) 10% DIF IVIG.

Nuffield Health Fitness & Wellbeing Finds Higher Retention Rate for Gym Members Who Undergo Health MOT

NEW WALDEN, England, November 22, 2010 – Nuffield Health Fitness & Wellbeing, part of the UK's largest healthcare
charity is attempting to change the way people look at their health.

Through its approach to keep their members motivated and educated their
aim is to improve their members' overall health for the long term … Original source on Gaea Times at : Nuffield Health Fitness & Wellbeing Finds Higher Retention Rate for Gym Members Who Undergo Health MOT.

Winners of Biodiversity Awards Revealed

MADRID, November 22, 2010 – Companies in the food sector, leading and pioneering efforts to promote
conservation and sustainable use of biodiversity, were honoured with
Biodiversity Awards on Tuesday 16 November. The Union for Ethical BioTrade
(UEBT) and United Business Media (UBM) revealed the winners at a ceremony
held at the Health Ingredients trade fair in Madrid, hosted … Read more »»».

HOYA Discusses the Future of Progressive Lenses on a Global Level

UITHOORN, Netherlands, November 24, 2010 – From 27 September until 1 October HOYA Vision Care invited a selection of
its best lens experts and VIP customers from all over the world to join its
Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new
technological developments and share vision and plans on the [..] Read the original article: here.

HOYA Faculty Education & Experience Centre Officially Opens its Doors

BUDAPEST, Hungary, November 24, 2010 – On Tuesday evening November 9th around 110 invitees witnessed the opening
ceremony of HOYA's new Faculty Education and Experience Centre in the heart
of Budapest.

Amongst the guests were Japanese Ambassador to Hungary Mr. Tecuo Ito and
deputy Mayor of the Fifth District of Budapest Mr. Andras Puskas.
… Original article on : HOYA Faculty Education & Experience Centre Officially Opens its Doors.

Elsevier Announces the 9th Pangborn Sensory Science Symposium

OXFORD, England, November 24, 2010 – Elsevier, the leading publisher of scientific,
technical and medical information products and services, today announced that
the 9th Pangborn Sensory Science Symposium (www.pangborn2011.com/ )
has been confirmed, taking place in Kyoto, Japan on 4-8 September 2011.

With the last symposium attracting 1000 delegates, Pangborn is the most
prestigious conference … Read : Elsevier Announces the 9th Pangborn Sensory Science Symposium.

AMT Submits Responses to Day 120 Questions to EMA as Part of the Review Process for Glybera(R)

AMSTERDAM, November 23, 2010 – Amsterdam Molecular Therapeutics (Euronext Amsterdam: AMT), a
leader in the field of human gene therapy, today announces that it has
submitted its responses to the Day 120 questions posed by the European
Medicines Agency (EMA) as part of the review process for Glybera(R), a gene
therapy for lipoprotein lipase deficiency (LPLD). As outlined … Read this article on Gaea Times at : AMT Submits Responses to Day 120 Questions to EMA as Part of the Review Process for Glybera(R).

Intelsius Adds Two New Category A Shipping Solutions to Line of Biotherm Packaging Systems

YORK, England, November 23, 2010 – Intelsius, a global manufacturer and distributor of environmentally safe,
temperature-controlled and regulatory-compliant packaging solutions, has
added two new Category A shipping systems to its existing line of Biotherm
packaging solutions.

(Logo: photos.prnewswire.com/prnh/20101012/DE80101LOGO )
Biotherm Category A shipping systems are designed to ensure full
compliance with IATA, … Original article on : Intelsius Adds Two New Category A Shipping Solutions to Line of Biotherm Packaging Systems.

Teva Launches Prednisolone EC Tablets

CASTLEFORD, England, November 23, 2010 – We are pleased to announce the launch of a generic version of
Prednisolone enteric-coated (EC) tablets.

Prednisolone EC tablets are a generic version of Deltacortril(R) from
Alliance Pharmaceuticals Limited and are indicated in the treatment of
inflammatory and allergic conditions such as asthma, rheumatoid arthritis and
colitis.
…. Source  : Teva Launches Prednisolone EC Tablets.

New Cervical Cancer Screening Test Set to Save the Lives of Women All Over the UK

Landmark Study Confirms Accuracy of Roche's Human Papillomavirus Test for the Detection of Cervical Pre-Cancer Missed by Existing Screening Methods

BURGESS HILL, England, November 24, 2010 – The largest ever registrational study for a diagnostic product, involving
more than 47,000 women shows that the cobas(R) 4800 Human Papillomavirus
(HPV) test from Roche, is able to improve the … Read more >>.

New CAMHS Tier 4 Service for Young People With Autism Opening December

POTTERS BAR, England, November 25, 2010 – The Hawksmere Centre, Healthcare and Education for Young People with
Autism, is the UK's first CAMHS Tier 4 service designed to meet the
challenging and complex needs of young people with autism and Asperger
syndrome. The Centre provides a national inpatient service, offering a safe
and secure environment which can respond …. Source article on Gaea Times at  : New CAMHS Tier 4 Service for Young People With Autism Opening December.

Almac Adds Late Stage Customisation Suite to Assist Orphan Drug / Niche Product Launches Into Europe

CRAIGAVON, Northern Ireland, November 25, 2010 – With a growing requirement to support our clients with their EU product
launches, reduce stock holdings and provide greater flexibility with regional
packs, Almac has added an additional dedicated Late Stage Customisation Suite
to the company's commercial facilities.

Mark English, Distribution Manager at Almac, explains, "Late stage
customisation …. Source article  : Almac Adds Late Stage Customisation Suite to Assist Orphan Drug / Niche Product Launches Into Europe.

Clinical Solutions at Forefront of NHS 111 With Launch of IntefleCS 111

Clinical Solutions' Highly Scalable Triage and Patient Prioritisation Support Solution to Provide Interoperability Across Urgent Care Settings

BASINGSTOKE, England, November 25, 2010 – Clinical Solutions, the national provider of telephone triage
and prioritisation software, has today announced the launch and initial
deployment of its scalable IntefleCS 111 solution.
IntefleCS 111 will integrate with 999 …. Source article on Gaea Times at  : Clinical Solutions at Forefront of NHS 111 With Launch of IntefleCS 111.

New Research Adds Weight to Exercise Helping Dieters Shed Pounds

LONDON, November 25, 2010 – Dieters should add regular exercise to their programmes in a bid to shed
those extra pounds – and keep them off.

Latest research reinforces the importance of combining healthy eating and
exercise with more than 90 per cent of those opting for this combination
reporting it as a successful …. Original source  : New Research Adds Weight to Exercise Helping Dieters Shed Pounds.

Sharp Eyesight Thanks to Proper Nutrients

Current Research: Lutein, Zeaxanthin and Omega-3 Fatty Acids are Essential for Keeping Eyes Healthy. Nutritional Supplements are Recommended at an Older Age.

FRANKFURT, November 25, 2010 – Who wouldn't want sharp and clear vision for a lifetime? Those who do
should take several specific micronutrients. A current scientific review
article has confirmed that an optimal supply of … Original source on Gaea Times at : Sharp Eyesight Thanks to Proper Nutrients.

Gerresheimer Continues to Invest in Prefilled Syringes

A Fourth Production Line for Prefilled Glass Syringes is Planned for the B??nde Plant (Germany)

DUSSELDORF, Germany, November 25, 2010 – Gerresheimer AG, one of the world's leading suppliers to the
pharma and healthcare industry, is making further investments in the growth
market for prefilled syringes. The three existing production lines for RTF(R)
syringes (Ready-To-Fill syringes) at the …. Original source  : Gerresheimer Continues to Invest in Prefilled Syringes.

Infusion Pump Markets (Large Volume, Ambulatory, Insulin, Enteral and Other Pumps) Now Available at ReportsandReports

DALLAS, November 25, 2010 – ReportsandReports announces it will carry Infusion Pump Markets (Large
Volume, Ambulatory, Insulin, Enteral and Other Pumps) Research Report in its
store.

Browse the complete Report on:
www.reportsandreports.com/reports/35298-infusion-pump-markets-large-
volume-ambulatory-insulin-enteral.html
Browse All Healthcare Reports:
www.reportsandreports.com/cat/healthcare-market-research.html
Search More Then 50000 Market Research Reports at ReportsandReports
(www.reportsandreports.com)
…. Original article on Gaea Times at  : Infusion Pump Markets (Large Volume, Ambulatory, Insulin, Enteral and Other Pumps) Now Available at ReportsandReports.

MarketsandMarkets: U.S Digestive Health Ingredients Market Worth $495.3 Million in 2015

DALLAS, November 29, 2010 – DIGESTIVE HEALTH INGREDIENTS MARKET -U.S. analyzes the trends prevailing
in the digestive health ingredients market (
www.marketsandmarkets.com/Market-Reports/digestive-health-225.html) in
the United States. It gives the revenue forecast, competitive structure and
market share details for major segments such as digestive prebiotics,
digestive probiotics and digestive enzymes. It analyzes the product and
application trend for the major product …. Source article  : MarketsandMarkets: U.S Digestive Health Ingredients Market Worth $495.3 Million in 2015.

New SmartVascular Software Optimizes Imaging in Vascular Surgery

Software Solution From Ziehm Imaging Optimizes Mobile Imaging Workflow and Delivers Results in Just a few Steps

NUREMBERG, Germany, November 29, 2010 – Ziehm Imaging's intuitive SmartVascular software considerably simplifies
imaging in vascular surgery. It introduces an entirely new workflow for fast
results. This solution raises efficiency levels, eliminates interim C-arm
operating steps and automates the imaging processes. … Original source on Gaea Times at : New SmartVascular Software Optimizes Imaging in Vascular Surgery.

Global Dental Implants Market (2010-2015) Now Available – Sandler Research

Sandler Research announces it will carry Global Dental Implants Market (2010 -2015) Research Report in its store.

DALLAS, November 29, 2010 – (Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)
Dental implants …. Source  : Global Dental Implants Market (2010-2015) Now Available – Sandler Research.

Nov 30th US Protests: ‘China, Pay Your Fair Share on Global AIDS!’

On Eve of World AIDS Day, Simultaneous Protests at China's Washington Embassy and Los Angeles Consulate Will Target China for Misuse of the Global Fund; Over Last Ten Years, World's Second-largest Economy Received Nearly $1 Billion from the Fund, but Contributed Just $16 Million

WASHINGTON, November 29, 2010 – On the eve of World AIDS …. Original source  : Nov 30th US Protests: 'China, Pay Your Fair Share on Global AIDS!'.

World to Turn (RED)(TM) to Mark World AIDS Day

Highlighting the Fight Against AIDS and the Attainable Goal of a Generation of Babies Born HIV-Free by 2015

NEW YORK, November 29, 2010 – More than 80 iconic landmarks across 13 countries will join (RED) to
promote awareness of the ongoing fight against the AIDS pandemic, by turning
red to mark World AIDS Day on 1st December. …. Read the original article  : World to Turn (RED)(TM) to Mark World AIDS Day.